Prosecution Insights
Prosecution Insights
10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (20%) |
| §112 only | 4 (40%) |
| No statute on record | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHTERENGARTS, SAMANTHA L | 1 | 79.4% | +7.9% |
| RAO, PADMAJA S | 1 | 69.5% | +35.9% |
| BORALSKY, LUKE ALAN | 1 | 100.0% | +0.0% |
| MACFARLANE, STACEY NEE | 1 | 53.3% | +39.2% |
| STONEBRAKER, ALYSSA RAE | 1 | 54.4% | +52.8% |
| SWARTWOUT, BRIANNA KENDALL | 1 | 46.0% | +62.0% |
| RZECZYCKI, PHILLIP MATTHEW | 1 | 57.4% | +45.0% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| WEIDNER, ADAM M | 1 | 63.6% | +33.9% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284654 | TETRAHYDRONAPHTHALENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE | BORALSKY, LUKE ALAN | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018471 | ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF | SWARTWOUT, BRIANNA KENDALL | 100d overdue |
| 18004532 | SULFONYLBENZAMIDE DERIVATIVE AND CONJUGATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | HERNANDEZ, JACKSON J | 70d overdue |
| 18561111 | PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOF | RAO, PADMAJA S | 67d overdue |
| 18013231 | ANTI-CD70 ANTIBODY AND APPLICATION THEREOF | WEIDNER, ADAM M | 53d overdue |
| 18039683 | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY | MACFARLANE, STACEY NEE | 24d overdue |
| 18017388 | SULFUR-CONTAINING ISOINDOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | RZECZYCKI, PHILLIP MATTHEW | 5d overdue |
| 17793005 | ANTI-TROP-2 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF | PUTTLITZ, KARL J | 2d overdue |
| 18032086 | ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF | STONEBRAKER, ALYSSA RAE | 14d |
| Art Unit | Apps |
|---|---|
| 1627 | 2 |
| 1675 | 2 |
| 1623 | 1 |
| 1624 | 1 |
| 1642 | 1 |
| 1644 | 1 |
| 1625 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18571909 | FUSED TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | SHTERENGARTS, SAMANTHA L | 1623 | §112 | Non-Final OA | 14d | Pending | Dec 19, 2023 |
| 18561111 | PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOF | RAO, PADMAJA S | 1627 | Other | Final Rejection | 67d overdue | Pending | Nov 15, 2023 |
| 18284654 | TETRAHYDRONAPHTHALENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE | BORALSKY, LUKE ALAN | 1624 | §103 | Non-Final OA | 14d | Pending | Sep 28, 2023 |
| 18039683 | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY | MACFARLANE, STACEY NEE | 1675 | §112 | Non-Final OA | 24d overdue | Pending | May 31, 2023 |
| 18032086 | ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF | STONEBRAKER, ALYSSA RAE | 1642 | Other | Non-Final OA | 14d | Pending | Apr 14, 2023 |
| 18018471 | ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF | SWARTWOUT, BRIANNA KENDALL | 1644 | Other | Non-Final OA | 100d overdue | Pending | Jan 27, 2023 |
| 18017388 | SULFUR-CONTAINING ISOINDOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | RZECZYCKI, PHILLIP MATTHEW | 1625 | §112 | Non-Final OA | 5d overdue | Pending | Jan 20, 2023 |
| 18004532 | SULFONYLBENZAMIDE DERIVATIVE AND CONJUGATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | HERNANDEZ, JACKSON J | 1627 | §103 | Non-Final OA | 70d overdue | Pending | Jan 06, 2023 |
| 18013231 | ANTI-CD70 ANTIBODY AND APPLICATION THEREOF | WEIDNER, ADAM M | 1675 | §112 | Non-Final OA | 53d overdue | Pending | Dec 27, 2022 |
| 17793005 | ANTI-TROP-2 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF | PUTTLITZ, KARL J | 1646 | Other | Non-Final OA | 2d overdue | Pending | Jul 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial